Member Info for Porky9

It's a massive point you make @researchandhold it really should not be underestimated the significance of the trial findings. Its absolutely game changing. Market clearly not caught up with this yet. I just think now with 4D share price being battered, shorted and totally smashed down it represents an opportunity for Merck to take out. I just think its a total no brainer for Merck. it totally supports their main cancer drug.

@Skeletor
I'm kind of on the same page as @Mikey279 you are assuming low volume days. The pressure is added shorts that will ultimately need to be brought back. Bronte for example are still 800,000 short. We do also have some key further updates to drop and they will likely encourage higher volumes. It would be good if one of the funds added to their position or someone new took a position as it would flush SO out if Nemean Asset still has any left and any shorter's with it for a major rebound.

@PhilGekko
He specifically says that he is in talks with Oxford Finance and the trial update was a milestone. The filing stateside allows them to raise on the NASDAQ end of this year if they need to, if Oxford extend further that could also give us a boost.

My own personal view is that the NASDAQ filing is actually a stroke of genius, reality is they wont need anything well into Q4 and if Oxford extend even better BUT what it does do is tell the market including Merck that they are secure and have no financial issues which prevents Merck low ball taking them out. I think the update last Wednesday is the biggest sign yet that Merck will acquire. If they don't one of the others will IMO which could cause Merck a problem longer term.

JUST OUT
Expect to expand drugs into other areas...
https://www.youtube.com/watch?v=GeSzbAIWmr4

I think its utterly disgusting to short a business actively trying to find a cure for cancer and other major illness. I think its shocking.

Some are actively cheering to try and smash the price down to 46p on the strength of some fictitious gap that apparently needs filling. Then what, oh it should 40p its should be 30p how about F'ck all p. If i had a quid for every gap that needs filling on a bloody chart i wouldn't need to buy shares.

I just think its bloody disgusting. We are all want to make money on the markets but i really draw a line at shorting stocks especially stocks in the Bio sector trying to make a difference.

1 in 3 can get Cancer and KARMA can be a *****. Lets hope they are not the one in three. Attitude might just be different.

GLA

After publication of the RNS this morning his precis was:-

"The company said its 2021 drilling campaign delivered 'proof of concept'. Its 2022 drilling campaign is supported by an integrated subsurface database pulling together information from 2D Seismic, multispectral satellite spectroscopy, electrical resistance tomography, airborne gravity gradiometry and QEMSCAN analysis – concepts one imagines at least 5% of shareholders understand."

He kind of does have a point, doesn't he? As i always say, if you cant blind with science baffle with bullsh@t. But the talking done now, time to walk the walk as others have pointed out, it really is.

Come on David, in plain English please, when are we going to start drilling, where are we drilling and with what? Who is the partner?

No more spectroscopy talk. Jeeze before i invested here i thought spectroscopy was something they did in hospitals with a camera up your arse.

Good luck all....

@PhilGekko
You jest but there probably is a charting pattern with that name, they make them up as they go along to support their short or long perspective
They will be telling us shortly they were right and that was the gap filled this morning, you couldn’t make it up

Still no charting excuses now, Should be onwards and upwards from here then....

If I were a fund or party that wanted a decent position here, knowing shorters have been targeting this stock, I would buy a small chunk, let the shorts move back in, buy another chunk and keep doing that. Repeat the process

Slowly it would reach boiling point and the shorts would be rushing to close and the SP rally. There was a reason why WINS wanted 12.5m in on Friday, I think there is a major interested party in the background

Time will tell

LMAO
L2 Flipped BIG Style
Watch the shorts run for the BUY exit to close

Accounts a tick Box - Job done

I was under the impression that the Rig had been chosen, it was able to do shallow drilling and was able to be broken down into sections which made it easier for shipping and was kind of a done deal once it had the once over from the engineer.

Drilling update has to land any moment surely??

GLA

Well as we know a short can only realise a gain from the SP going down when they buy the stock the back. There is so much short stock here that there will be a stampede on buying back, last one to close will find it expensive.

What we do have on the Bull side is the fact that we have further updates any moment. That is sure to add to our strength and act as a further catalyst to a share price rebound as they land.

GLA

Issued late on Friday the Bio Pharma Reporter article:-
https://www.biopharma-reporter.com/Article/2022/03/25/4d-pharma-new-data-early-indication-lbps-may-help-to-overcome-resistance-to-checkpoint-inhibitors

Interesting Read

Should be an interesting week with new investor interest on top of all the shorts that need buying back not to mention at least two more updates due Bavencio and pancreatic enrollment completed

Plus FDA update any moment, Blautix fast track anyone? Crazy times....

Stock is news led with the update on Wednesday confirming proof of Concept which should further support the other LBPs in the range not to mention the wider Microbiome Biotech Sector.

If you are into charting, swingtradebot went from Bearish on 24th to Bullish into strength on the 25th:-
https://lse.swingtradebot.com/equities/DDDD:LSE

12.5m of stock WINS were trying to get in late Friday not sure if a Buyer lined up but an interesting development for sure which will make shorters think????

Personally i'm not concerned on short activity, ultimately it has to be brought back. Would not want to be the last one holding a short position to close could get really expensive. Mind you would be a bit of poetic justice.

GLA

GLA

Reposted link as Tiny URL:-
https://tinyurl.com/2p9b4yp3

Be interested to see what Merck's next move will be now, especially as they know this significantly supports Keytrunda.
GLA

Precis of the update
https://www.**********.co.uk/articles/4d-pharma-meets-primary-efficacy-endpoint-in-kidney-cancer-study--126f6c0/

Scouse
Head over to the house broker CENKOS and register with them its free. Anything posted on a board is just opinion.
https://www.cenkos.com/research-portal/

You can then download the full report including current and estimated cash burn and the full facts.

The estimated cash at end of Dec 21 was £598k. The historic cash burn has been £350k per quarter but Cenkos are hopeful of a further reduction in costs going forwards although two uni deals were signed one at £100k and one at £75k hence that will add to cash burn. On the income side they are also getting $10k USD a month from the Theo service arrangement.

The exact cash position will be known when they issue the Full year results. Last year this was on 27th April so i suspect it could be out at a similar time.

Good Luck

@Harchris
One vital bit missing from your analysis and that is that would be shorting chancers, like the poster Masterblast here, opened short positions to further support the the price drop. In fact the short numbers were substantial.

Situation is that these shorts will need closing, I wouldn't want to be the last short to close next week, could get very expensive for them.

The intra day high was 71p on Wednesday, with SO dumping so much stock and shorters joining the party it retracted to 50p, not many short will have sold that high hence why many are still open and need buying back and desperate to get this price down further, they are hoping for more BUT frankly i don't see it happening.

The news was significant, market just catching on. There is also a stack of further news due on this over the next week. it was a breakthrough on Wednesday i wouldn't be surprised if Merck make a move now.

Also, WINS were fishing for 12.5m shares at 50p Friday, i thought wow, they will never get that much stock in. Made me wonder if they have a major buyer or fund lined up, so i cant see the SP being under further pressure now, more likely more buyers will move in.

From my own perspective i certainly wont be selling at these levels that's for sure, not after Wednesday's break through news business is better positioned than ever and further proof of concept. I'm adding at these levels,

See how events unfold.

Pork's

Hey if they want to de-ramp who cares. Can't stop a rolling waggon. The scene is set, LBPs work...
We are going far North next week

As i see it at least two more updates due next week, Bavencio and pancreatic enrollment completed.

BUT much more to come on top, still awaiting FDA update, Blautix fast track anyone?

Lets also see how the well the ground breaking news is syndicated this weekend. This is Money gave us a Nod, so did the times, Sundays could also pick it up.

Convinced a fund or otherwise will make a move, this is groundbreaking.

I Remain VERY positive, GL, Have a great weekend

Over 12.5 m Shares on the Bid 50p

Anyone wants to exit go for it, anyone want to short go for it, its sitting there..... come and get it...

I think today marks the end of the Retail squeeze. No way on this planet is that going to go after the amazing update. Why we are not north of a quid already totally defies all known logic,

Good luck for next week guys, its happening...

Seriously, call me Rampy McRampface if you like BUT I'm totally convinced the SP is going to blow big time next week
You don't release ground breaking trial data this amazing and not expect a major move to be made.
It's going to happen.

Based on L2 activity today i believe its building up. I'm totally convinced.

Watch this space. BUY and HOLD on tight

GLA

On L2
WINS have a bucket load on the bid at .50 if Nemean has still got any stock left and i seriously don't think they have they could complete based on the available volume.

Someone out there wants in here BIG style, hold your hats guys i think next week is going to be explosive,

GLA